Periprosthetic joint infections at a teaching hospital in 1990-2007

Canadian Journal of Surgery

Volumn 55, Issue 6, 2012, Pages 394-400

  Renaud, Alexandre ^a   Lavigne, Martin ^a   Vendittoli, Pascal André ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; COMORBIDITY; FEMALE; FOLLOW UP; HEMATOMA; HIP ARTHROPLASTY; HOSPITAL READMISSION; HUMAN; INFECTION; KNEE ARTHROPLASTY; LENGTH OF STAY; MALE; MEDICAL RECORD; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; TEACHING HOSPITAL; WOUND DEHISCENCE;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HEMATOMA; HOSPITALS, TEACHING; HUMANS; LENGTH OF STAY; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT READMISSION; PROSTHESIS-RELATED INFECTIONS; QUEBEC; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND DEHISCENCE;

EID: 84872865213     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: 10.1503/cjs.033610     Document Type: Article

References (52)

1. Pulido L, Ghanem E, Joshi A, et al. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008; 466:1710-5.
2. Dowsey MM, Choong PF. Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty. Clin Orthop Relat Res 2008; 466:153-8.
3. Phillips JE, Crane TP, Noy M, et al. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br 2006;88:943-8.
4. Betsch BY, Eggli S, Siebenrock KA, et al. Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis 2008;46:1221-6.
5. Jämsen E, Varonen M, Huhtala H, et al. Incidence of prosthetic joint infections after primary knee arthroplasty. J Arthroplasty 2010;25:87-92.
6. Peersman G, Laskin R, Davis J, et al. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 2001;(392):15-23.
7. Blom AW, Brown J, Taylor AH, et al. Infection after total knee arthroplasty. J Bone Joint Surg Br 2004;86:688-91.
8. Huotari K, Lyytikainen O. Impact of postdischarge surveillance on the rate of surgical site infection after orthopedic surgery. Infect Control Hosp Epidemiol 2006;27:1324-9.
9. Kurtz SM, Lau E, Schmier J, et al. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008;23:984-91.
10. Ong KL, Kurtz SM, Lau E, et al. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty 2009; 24(Suppl):105-9.
11. Furnes O, Espehaug B, Lie SA, et al. Failure mechanisms after unicompartmental and tricompartmental primary knee replacement with cement. J Bone Joint Surg Am 2007;89:519-25.
12. Kurtz SM, Ong KL, Lau E, et al. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res 2010;468:52-6.
13. Bratzler DW, Houck PM, Richards C, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005;140:174-82.
14. Eiselt D. Presurgical skin preparation with a novel 2% chlorhexidine gluconate cloth reduces rates of surgical site infection in orthopaedic surgical patients. Orthop Nurs 2009;28:141-5.
15. Darouiche RO, Wall MJ Jr, Itani KM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010; 362:18-26.
16. Sanzén L, Carlsson AS, Walder M. Air contamination during total hip arthroplasty in an ultraclean air enclosure using different types of staff clothing. J Arthroplasty 1990;5:127-30.
17. Learmonth ID. Prevention of infection in the 1990s. Orthop Clin North Am 1993;24:735-41.
18. Scheibel JH, Jensen I, Pedersen S. Bacterial contamination of air and surgical wounds during joint replacement operations. Comparison of two different types of staff clothing. J Hosp Infect 1991;19:167-74.
19. Al-Maiyah M, Bajwa A, Mackenney P, et al. Glove perforation and contamination in primary total hip arthroplasty. J Bone Joint Surg Br 2005;87:556-9.
20. McCue SF, Berg EW, Saunders EA. Efficacy of double-gloving as a barrier to microbial contamination during total joint arthroplasty. J Bone Joint Surg Am 1981;63:811-3.
21. Byrne AM, Morris S, McCarthy T, et al. Outcome following deep wound contamination in cemented arthroplasty. Int Orthop 2007;31:27-31.
22. Pryor F, Messmer PR. The effect of traffic patterns in the OR on surgical site infections. AORN J 1998;68:649-60.
23. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999;20:250-78, quiz 79-80.
24. Hughes SP, Anderson FM. Infection in the operating room. J Bone Joint Surg Br 1999;81:754-5.
25. Innerhofer P, Klingler A, Klimmer C, et al. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion 2005;45:103-10.
26. Parvizi J, Ghanem E, Joshi A, et al.Does "excessive" anticoagulation predispose to periprosthetic infection? J Arthroplasty 2007;22(Suppl 2):24-8.
27. Minnema B, Vearncombe M, Augustin A, et al. Risk factors for surgical-site infection following primary total knee arthroplasty. Infect Control Hosp Epidemiol 2004;25:477-80.
28. Lentino Jr. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis 2003;36:1157-61.
29. Brander V, Stulberg SD. Rehabilitation after hip- and knee-joint replacement. An experience- and evidence-based approach to care. Am J Phys Med Rehabil 2006;85(11 Suppl):S98-118, quiz S9-23.
30. Namba RS, Paxton L, Fithian DC, et al. Obesity and perioperative morbidity in total hip and total knee arthroplasty patients. J Arthroplasty 2005;20(Suppl 3):46-50.
31. Patel VP, Walsh M, Sehgal B, et al. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am 2007;89:33-8.
32. Dowsey MM, Choong PF. Obese diabetic patients are at substantial risk for deep infection after primary TKA. Clin Orthop Relat Res 2009;467: 1577-81.
33. Jaberi FM, Parvizi J, Haytmanek CT, et al. Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty. Clin Orthop Relat Res 2008;466:1368-71.
34. Mittal Y, Fehring TK, Hanssen A, et al. Two-stage reimplantation for periprosthetic knee infection involving resistant organisms. J Bone Joint Surg Am 2007;89:1227-31.
35. Drinkwater CJ, Neil MJ. Optimal timing of wound drain removal following total joint arthroplasty. J Arthroplasty 1995;10:185-9.
36. Wald HL, Ma A, Bratzler DW, et al. Indwelling urinary catheter use in the postoperative period: analysis of the national surgical infection prevention project data. Arch Surg 2008;143:551-7.
37. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996;78:512-23.
38. Hernigou P, Flouzat-Lachianette CH, Jalil R, et al. Treatment of infected hip arthroplasty. Open Orthop J 2010;4:126-31.
39. Jämsen E, Huhtala H, Puolakka T, et al. Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am 2009;91:38-47.
40. Saleh K, Olson M, Resig S, et al. Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program. J Orthop Res 2002;20:506-15.
41. Drancourt M, Argenson JN, Tissot Dupont H, et al. Psoriasis is a risk factor for hip-prosthesis infection. Eur J Epidemiol 1997;13:205-7.
42. Lai K, Bohm ER, Burnell C, et al. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J Arthroplasty 2007;22:651-6.
43. Parvizi J, Sullivan TA, Pagnano MW, et al. Total joint arthroplasty in human immunodeficiency virus-positive patients: an alarming rate of early failure. J Arthroplasty 2003;18:259-64.
44. Powell DL, Whitener CJ, Dye CE, et al. Knee and hip arthroplasty infection rates in persons with haemophilia: a 27 year single center experience during the HIV epidemic. Haemophilia 2005;11:233-9.
45. Chiu FY, Chen CM, Lin CF, et al. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg Am 2002;84-A:759-62.
46. Chiu FY, Lin CF, Chen CM, et al. Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus. A prospective, randomised study. J Bone Joint Surg Br 2001;83:691-5.
47. Espehaug B, Engesaeter LB, Vollset SE, et al. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br 1997;79:590-5.
48. Malchau H, Herberts P, Ahnfelt L. Prognosis of total hip replacement in Sweden. Follow-up of 92,675 operations performed 1978-1990. Acta Orthop Scand 1993;64:497-506.
49. Knobben BA, van Horn JR, van der Mei HC, et al. Evaluation of measures to decrease intra-operative bacterial contamination in orthopaedic implant surgery. J Hosp Infect 2006;62:174-80.
50. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004;38:1706-15.
51. Glenny A, Song F. Antimicrobial prophylaxis in total hip replacement: a systematic review. Health Technol Assess 1999;3:1-57.
52. Tang WM, Chiu KY, Ng TP, et al. Efficacy of a single dose of cefazolin as a prophylactic antibiotic in primary arthroplasty. J Arthroplasty 2003;18:714-8.